Share On

The Pharma and life science industry continuously adapt and evolve with the latest technological trends like IoT, 3D printing, cloud and so on to meet the requirements in the industry. These innovations imbibe the potential to change the basics of the industry by offering improved patient and healthcare professional engagement, better services for patients, higher productivity and so on. The backbone of the Pharma and life science industry is its research and development (R&D) sector. Therefore, to meet the demands of the industry, companies are seeking methods to improve and enhance the R&D sector with the help of information technology.

The initiation of cloud in the industry aids to connect the extended supply chain. For example, information and data from the manufacturing execution systems (MES) and laboratory information management systems (LIMS) can be linked with each other with the help of the cloud technology. The most important component of science is data and the value derived from it. Cloud-based software solves the problem of massive unstructured data, which can be accessed from a single place. The cloud-based software can transform the way scientists perform their experiments by connecting their personal instruments directly to the cloud. When all the data and events are logged, the results of the experiments and the records are seamlessly visible across the entire workflow and project, which in turn enhances the whole process and the outcome.

Big data is another massive game changer in the pharma and life sciences industry. Pharmaceutical firms own massive data that includes patient to supply chain information, the digitization that has happened in the recent years, have made it possible to access this huge volume of data through software, making big data an important factor. The systematic analysis of this big data enhances the success of the industry to a large extent. By implementing big data management systems, businesses can perform better. These management systems can mine previously remote data and unlock the necessary information from unstructured and structured data in a very short period of time. The analytics of these huge volumes of data helps the medical professionals to detect the disease in an early stage by the analysis of the prescription and the treatment patterns. Implementing big data management systems will also aid scientists to derive insights across the entire drug development life cycle. Big data analytics is an exceptional tool that helps to understand relationships and the trends prevailing in the large volumes of data in the industry. The data sets will comprise of prescription orders, customer feedback, transaction records, clinical data, and so on in an accessible way to pharmaceutical companies, which can be used for further strengthening of the company.

By implementing data analysis in the Pharma and life science industry, provides significant value-creation potential. By harnessing the power of data through analytics, scientists will be enabled to source their scientific findings from labs or internal knowledge to enhance discovery, which will also help to reduce cycle time for product development. The risk analytics will aid to evaluate the probable risk posed by elemental impurities in a drug product, which is formulated. Therefore, pharmaceutical organizations should make maximum use of big data and analytics for a better future.

Accelerating the Improved Patient Journey through Real World Evidence

White Paper By: SHYFT Analytics, Inc.

Why Real World Evidence (RWE) is important to drive improvements in patient outcomes? Real World Evidence (RWE) has long been heralded as a “game changer” for the life sciences industry. Real World Evidence is the term used to describe research findings that use data that is gathered outside of standard clinical trials. This informative whitepaper highlights the...

The Value of the State Immunization Registry Program to Improve Vaccination Rates and Quality of Care in Retail Pharmacies

White Paper By: Scientific Technologies Corporation

The state immunization registry, or immunization information system (IIS), is an important resource for consolidated patient immunization records so that vaccination providers can access this information.Over the years state immunization registry have evolved into sophisticated data management and clinical decision support tools for vaccination providers. Read this informative whitepaper...

Biomarkers and Acute Kidney Injury (AKI): Pre-analytical Considerations are Critical for Early Detection of AKI

White Paper By: Pacific Biomarkers

Biomarkers for the prediction of acute kidney injury: A review on current status and future challenges Biomarker of acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in critically ill patients. The approach to analyzing AKI biomarkers has been to provide pharmaceutical and biotech companies with services for testing robust novel biomarkers that...

Incretins & Gastrointestinal Hormones: Pathophysiology and Pre-analytical Considerations

White Paper By: Pacific Biomarkers

Testing for incretins, and other gut hormones, presents numerous challenges because of their instability. Therefore, proper sample collection and meticulous pre-analytical and analytical sample handling are crucial for successful quantification of these biomarkers. Incretins, which are insulinotropic gastrointestinal hormones, are produced mainly in K and L cells of the small intestine under...

Integrating FDA GLP Compliant Capabilities into a CAP/Clinical Trials Production Laboratory: An Alternate Approach

White Paper By: Pacific Biomarkers

Good Laboratory Practices (GLP): In order to enhance patient safety and improve the quality of testing performed in laboratories, there is a need for integrating good laboratory practices. There are many areas and processes that a laboratory should consider before adding waived testing to the panel of services. Incorporating FDA GLP capabilities into CAP/clinical facility poses...

Considerations for Modernizing Scientific Compute Research Platforms

White Paper By: Avere Systems

Present life sciences research organizations deals with petabytes of data which requires new performance and data management for IT infrastructures and storage solutions. To address the performance and data management issues found in life sciences organizations, a high performance hybrid file system is used which stores data closets to compute resources that can modernize infrastructure...

follow on linkedin follow on twitter follow on facebook 2018 All Rights Reserved | by: www.ciowhitepapersreview.com